BigKNY3, surely you know by now that I'm not naive enough to try to influence VVUS stock price by posting.
And what I posted is not a press release but a work-in-progress by the American College of Cardiology, I happened to see the URL in a Journal today so I pulled it out. The original work had not been posted, only the press releases, and I hate to interpret things through press releases. Perhaps it had on the PFE thread, but I generally don't read or post on stock threads where I have no vested interest. Certainly the date was clear enough that you and everyone could see, it is not news. But it is a basic report on the position of a well established medical society on the most widely used drug for ED out there.
And it contains cautions that the manufacturer of this drug has not seen fit to disseminate regarding their product.
As you well know, the "learned intermediary" principal protects the drug manufacturer from liability if they have fully informed the intermediary of the risks of the product. The fact that the ACC has seen fit to issue a warning that is greater than that issued by PFE suggests that PFE may face exposure for that additional risk of which they have not informed the intermediaries.
The only reason I'm still long on VVUS is the product, (and you thought it was the management). This product has been overshadowed by a product, Viagra, that in my professional opinion, has a significantly greater risk to the target population than does this product, Muse.
You may go back to a year ago and find my posts that addressed this issue. The fact that professional organizations and other country's Medical agencies now seem to concur with what I was saying is new news. The fact that you could have read my posts almost a year ago and heard similar cautions about a systemic drug for a local problem is evidence only that I have not seen fit to change my opinion. I guess that is old news. But now it is reinforced by my clinical experience with both treatments.
If PFE is so strong, why does it require such vigilant defense? Certainly, the converse of your premise <<It reinforces my belief that perceived "negative" Viagra news has no impact on the price of VVUS.>> must be true, that positive VVUS news has no impact on PFE. However, could it be that negative Viagra news has a negative impact on the price of PFE stock? <<If you have any doubt, just check the direction of VVUS and PFE since August 10th.>> If you have any doubt just check the price of PFE stock from July 15th to the present, and yes, PFE fell over 10% in market cap since August 10th, having since recovered a bit today.
Zebra |
